Biotech

Biological cancer treatment company Novellus raises $57 million

22.09.20 | Tzally Greenberg

Immunai Announces $20 Million Seed Round to Fund Immune System Mapping

14.05.20 | Hagar Ravet

Biomed Company CartiHeal Considers a Nasdaq IPO

26.02.20 | Golan Hazani

Healthtech Is Israel’s Next Growth Engine, Says Venture Capitalist

21.02.20 | Sophie Shulman

Peregrine Ventures Raises Fourth $115 Million Fund

09.12.19 | CTech

Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch

29.10.19 | Sophie Shulman

Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO

15.10.19 | CTech

Ophectra Signs Merger Deal With Meat Bioprinting Company MeaTech

03.10.19 | Ori Galor and Tzally Greenberg

New York-Based Financial Services Firm Jefferies to Join Tel Aviv Stock Exchange

02.06.19 | Raheli Bindman

RM Global Raises Additional $34 Million for Israel-Based Biopharma Investment Fund

09.04.19 | CTech

Can-Fite BioPharma to Raise $3.2 Million in Direct Offering

04.04.19 | CTech

Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million

28.03.19 | Lilach Baumer

Anchiano Therapeutics Stock Falls on Nasdaq IPO

13.02.19 | Lilach Baumer

Cancer Screening Company Check-Cap Crashes on $7.5 Million Nasdaq Direct Offering

05.02.19 | Lilach Baumer

Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason

10.01.19 | Lilach Baumer

Celgene Backs Immunotherapy Company Biond Biologics

08.01.19 | Meir Orbach

Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals

24.12.18 | Lilach Baumer

Lonza Opens Israeli Innovation Center

20.11.18 | Lilach Baumer

Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas

12.11.18 | Lilach Baumer

Biotech Company Polypid Raises $15 Million

07.11.18 | Lilach Baumer

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18 | Lilach Baumer

Israel to Help Biotech Companies Go from Research to Manufacturing

04.11.18 | Omri Milman

Former Teva Executives Raise $60 Million for Metabolic Disorders Venture

28.10.18 | Lilach Baumer

Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO

28.10.18 | Lilach Baumer

Global Licensing and Commercialization Deal Catapults Collplant on Nasdaq

22.10.18 | Lilach Baumer

LogicBio Therapeutics Underperforms with $70 Million Nasdaq IPO

21.10.18 | Lilach Baumer

Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million

18.10.18 | Lilach Baumer

Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO

30.09.18 | Dror Reich

Automated Blood Tests Startup MeMed Raises $70 Million to Expand Offering

20.09.18 | Omer Kabir

Antiseptic Materials Startup Nobio Raises $3.6 Million

30.07.18 | Asaf Shalev